UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets
Cash	$ 92,868	$ 75,052
Accounts and other receivables, net (note 2)	3,391	5,538
Inventories (note 2)	9,582	8,814
Prepaid expenses and other current assets	428	515
Total current assets	106,269	89,919
Property and equipment, net (notes 4 and 10)	10,551	10,224
Goodwill	13,692	13,354
Other intangible assets (note 2)	$ 54,296	$ 52,755
Operating Lease, Right-of-Use Asset, Statement of Financial Position	Other intangible assets (note 2)	Other intangible assets (note 2)
Other intangible assets - accumulated amortization	$ (49,350)	$ (42,378)
Other intangible assets, net (note 2)	4,946	10,377
Total assets	135,458	123,874
Current liabilities
Accounts payable	769	1,218
Accrued expenses (note 2)	$ 3,941	4,742
Operating Lease, Liability, Current, Statement of Financial Position	Accrued expenses (note 2)
Total current liabilities	$ 4,710	5,960
Long term lease liability	295	341
Long term income tax payable (REPAT tax) (note 7)	698	1,256
Deferred tax liability - intangible assets	1,120	1,514
Deferred income taxes (note 7)	322	549
Total liabilities	7,145	9,620
Commitments and contingencies (notes 6 and 12)	0	0
Stockholders' equity
Common stock, $.01 par value; 50,000 shares authorized, issued 3,630 shares in 2023 and 3,628 shares in 2022	36	36
Accumulated other comprehensive loss	(10,658)	(12,039)
Additional paid-in capital	594	251
Retained earnings	138,341	126,006
Total stockholders' equity	128,313	114,254
Total liabilities and stockholders' equity	$ 135,458	$ 123,874